BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 17375136)

  • 1. A large case-control study of common functional SLC6A4 and BDNF variants in obsessive-compulsive disorder.
    Wendland JR; Kruse MR; Cromer KR; Murphy DL
    Neuropsychopharmacology; 2007 Dec; 32(12):2543-51. PubMed ID: 17375136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association studies of serotonin system candidate genes in early-onset obsessive-compulsive disorder.
    Dickel DE; Veenstra-VanderWeele J; Bivens NC; Wu X; Fischer DJ; Van Etten-Lee M; Himle JA; Leventhal BL; Cook EH; Hanna GL
    Biol Psychiatry; 2007 Feb; 61(3):322-9. PubMed ID: 17241828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Polymorphism of the Serotonin Transporter Gene, SLC6A4 rs16965628, Is Associated with Obsessive Compulsive Disorder.
    Cengiz M; Okutan SN; Bayoglu B; Sakalli Kani A; Bayar R; Kocabasoglu N
    Genet Test Mol Biomarkers; 2015 May; 19(5):228-34. PubMed ID: 25751280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extensive genotyping of the BDNF and NTRK2 genes define protective haplotypes against obsessive-compulsive disorder.
    Alonso P; Gratacòs M; Menchón JM; Saiz-Ruiz J; Segalàs C; Baca-García E; Labad J; Fernández-Piqueras J; Real E; Vaquero C; Pérez M; Dolengevich H; González JR; Bayés M; de Cid R; Vallejo J; Estivill X
    Biol Psychiatry; 2008 Mar; 63(6):619-28. PubMed ID: 17884018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the functional serotonin transporter haplotype with familial form of obsessive compulsive disorder in Iranian patients.
    Rashidi FS; Ahmadipour E; Shiravand S; Ahmadiani A; Asadi S; Shams J
    Int J Psychiatry Clin Pract; 2018 Mar; 22(1):47-53. PubMed ID: 28691545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining genetic and epigenetic parameters of the serotonin transporter gene in obsessive-compulsive disorder.
    Grünblatt E; Marinova Z; Roth A; Gardini E; Ball J; Geissler J; Wojdacz TK; Romanos M; Walitza S
    J Psychiatr Res; 2018 Jan; 96():209-217. PubMed ID: 29102815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association study between obsessive-compulsive disorder and serotonergic candidate genes.
    Saiz PA; Garcia-Portilla MP; Arango C; Morales B; Bascaran MT; Martinez-Barrondo S; Florez G; Sotomayor E; Paredes B; Alvarez C; San Narciso G; Carreño E; Bombin I; Alvarez V; Coto E; Fernandez JM; Bousoño M; Bobes J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):765-70. PubMed ID: 18191318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common and rare alleles of the serotonin transporter gene, SLC6A4, associated with Tourette's disorder.
    Moya PR; Wendland JR; Rubenstein LM; Timpano KR; Heiman GA; Tischfield JA; King RA; Andrews AM; Ramamoorthy S; McMahon FJ; Murphy DL
    Mov Disord; 2013 Aug; 28(9):1263-70. PubMed ID: 23630162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The current status of association studies in obsessive-compulsive disorder.
    Hemmings SM; Stein DJ
    Psychiatr Clin North Am; 2006 Jun; 29(2):411-44. PubMed ID: 16650716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex determines which section of the SLC6A4 gene is linked to obsessive-compulsive symptoms in normal Chinese college students.
    Lei X; Chen C; He Q; Chen C; Moyzis RK; Xue G; Chen X; Cao Z; Li J; Li H; Zhu B; Chun Hsu AS; Li S; Li J; Dong Q
    J Psychiatr Res; 2012 Sep; 46(9):1153-60. PubMed ID: 22727904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association analysis of SLC6A4 and HTR2A genes with obsessive-compulsive disorder: Influence of the STin2 polymorphism.
    Gomes CKF; Vieira-Fonseca T; Melo-Felippe FB; de Salles Andrade JB; Fontenelle LF; Kohlrausch FB
    Compr Psychiatry; 2018 Apr; 82():1-6. PubMed ID: 29331882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of SLC6A4 variants with obsessive-compulsive disorder in a large multicenter US family study.
    Voyiaziakis E; Evgrafov O; Li D; Yoon HJ; Tabares P; Samuels J; Wang Y; Riddle MA; Grados MA; Bienvenu OJ; Shugart YY; Liang KY; Greenberg BD; Rasmussen SA; Murphy DL; Wendland JR; McCracken JT; Piacentini J; Rauch SL; Pauls DL; Nestadt G; Fyer AJ; Knowles JA
    Mol Psychiatry; 2011 Jan; 16(1):108-20. PubMed ID: 19806148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BDNF Val66Met polymorphism and plasma levels in Chinese Han population with obsessive-compulsive disorder and generalized anxiety disorder.
    Wang Y; Zhang H; Li Y; Wang Z; Fan Q; Yu S; Lin Z; Xiao Z
    J Affect Disord; 2015 Nov; 186():7-12. PubMed ID: 26209750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HT3 receptor influences the washing phenotype and visual organization in obsessive-compulsive disorder supporting 5-HT3 receptor antagonists as novel treatment option.
    Lennertz L; Wagner M; Grabe HJ; Franke PE; Guttenthaler V; Rampacher F; Schulze-Rauschenbach S; Vogeley A; Benninghoff J; Ruhrmann S; Pukrop R; Klosterkötter J; Falkai P; Maier W; Mössner R
    Eur Neuropsychopharmacol; 2014 Jan; 24(1):86-94. PubMed ID: 23928294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the brain-derived neurotrophic factor (BDNF) val66met variant in the phenotypic expression of obsessive-compulsive disorder (OCD).
    Katerberg H; Lochner C; Cath DC; de Jonge P; Bochdanovits Z; Moolman-Smook JC; Hemmings SM; Carey PD; Stein DJ; Sondervan D; Boer JA; van Balkom AJ; Polman A; Heutink P
    Am J Med Genet B Neuropsychiatr Genet; 2009 Dec; 150B(8):1050-62. PubMed ID: 19219856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A brain-derived neurotrophic factor haplotype is associated with therapeutic response in obsessive-compulsive disorder.
    Real E; Gratacòs M; Soria V; Escaramís G; Alonso P; Segalàs C; Bayés M; de Cid R; Menchón JM; Estivill X
    Biol Psychiatry; 2009 Oct; 66(7):674-80. PubMed ID: 19589503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between obsessive-compulsive disorder and a variable number of tandem repeats polymorphism in intron 2 of the serotonin transporter gene.
    Baca-Garcia E; Vaquero-Lorenzo C; Diaz-Hernandez M; Rodriguez-Salgado B; Dolengevich-Segal H; Arrojo-Romero M; Botillo-Martin C; Ceverino A; Piqueras JF; Perez-Rodriguez MM; Saiz-Ruiz J
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):416-20. PubMed ID: 17174018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin system genes and obsessive-compulsive trait dimensions in a population-based, pediatric sample: a genetic association study.
    Sinopoli VM; Erdman L; Burton CL; Park LS; Dupuis A; Shan J; Goodale T; Shaheen SM; Crosbie J; Schachar RJ; Arnold PD
    J Child Psychol Psychiatry; 2019 Dec; 60(12):1289-1299. PubMed ID: 31321769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of the serotonin transporter polymorphism and obsessive-compulsive disorder: systematic review.
    Bloch MH; Landeros-Weisenberger A; Sen S; Dombrowski P; Kelmendi B; Coric V; Pittenger C; Leckman JF
    Am J Med Genet B Neuropsychiatr Genet; 2008 Sep; 147B(6):850-8. PubMed ID: 18186076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of serotonin transporter gene polymorphisms with obsessive-compulsive disorder (OCD) in a south Indian population.
    Tibrewal P; Kumar HB; Shubha GN; Subhashree D; Purushottam M; Thennarasu K; Reddy YC; Jain S
    Indian J Med Res; 2010 Dec; 132(6):690-5. PubMed ID: 21245616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.